Q1 2021 Holdings
Filed 2021-05-14 | 72 holdings | $55.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $35.6M | 577,500 | 64.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $5.6M | 222,267 | 10.1% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $3.6M | 300,000 | 6.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $2.7M | 130,000 | 4.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $2.6M | 20,000 | 4.7% |
| Butterfly Network Inc(BFLY) | COM CL A | 124155102 | $1.7M | 100,000 | 3.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $930.0K | 40,000 | 1.7% |
| Acutus MED Inc(AFIB) | COM | 005111109 | $802.0K | 60,000 | 1.4% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $740.0K | 20,000 | 1.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $566.0K | 10,000 | 1.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $387.0K | 50,000 | 0.7% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $43.6K | 110,000 | 0.1% |
| ARK ETF TR(ARKG)Put | GENOMIC REV ETF | 00214Q302 | $21.3K | 240,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $12.3K | 195,000 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $11.3K | 1,000,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX)Call | COM | 92532F100 | $10.7K | 50,000 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $10.5K | 543,010 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $10.3K | 365,000 | 0.0% |
| Arya Sciences Acquisition Co | COM CL A | G3166W106 | $9.5K | 689,000 | 0.0% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $7.3K | 700,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $6.1K | 45,000 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $5.5K | 220,000 | 0.0% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $5.4K | 50,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX)Call | COM | 87164F105 | $4.3K | 190,500 | 0.0% |
| Retrophin Inc | NOTE 2.500% 9/1 | 761299AB2 | $4.1K | $4,000,000 | 0.0% |
| Lifesci Acquisition II Corp | COM | 53229E103 | $4.1K | 400,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $3.8K | 85,000 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $3.7K | 227,500 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $3.7K | 270,000 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $3.4K | 77,500 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $3.2K | 35,000 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $3.0K | 900,000 | 0.0% |
| Medicus Sciences Acquisition | UNIT 99/99/9999 | G5960S116 | $3.0K | 300,000 | 0.0% |
| Curis Inc(CRISEUR)Call | COM NEW | 231269200 | $2.8K | 250,000 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $2.7K | 175,000 | 0.0% |
| Cyclacel Pharmaceuticals Inc | COM | 23254L603 | $2.7K | 380,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $2.6K | 90,000 | 0.0% |
| Ascendis Pharma A/S(ASND)Put | SPONSORED ADR | 04351P101 | $2.6K | 20,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.6K | 100,000 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $2.5K | 80,000 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $2.5K | 225,000 | 0.0% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $2.1K | 45,000 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $2.0K | 27,000 | 0.0% |
| Rubius Therapeutics IncCall | COM | 78116T103 | $1.9K | 70,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $1.8K | 80,000 | 0.0% |
| Highcape Cap Acquisition COR | COM SL A | 42984L105 | $1.8K | 150,000 | 0.0% |
| Bluebird BIO IncCall | COM | 09609G100 | $1.5K | 50,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $1.4K | 85,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $1.3K | 50,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $1.2K | 300,000 | 0.0% |